Therefore, XRCC2 polymorphisms may take part dominant role in colorectal cancer tumorigenesis, conferring susceptibility to rectal tumors in Polish population (Romanowicz et al., 2016). This evidence concerns the gene XRCC2 and rectal neoplasm.